|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.9292 - 1.0100|
|52 Week Range||0.7283 - 1.6750|
|Beta (3Y Monthly)||2.79|
|PE Ratio (TTM)||28.16|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In this article, we’ll discuss Curaleaf Holdings’ (LDVTF) valuation as of November 27 and its comparison with its peers, including WeedMD (WDDMF), Trulieve (TCNNF), and Maricann (MRRCF).
In this part of our series, we take a look at the stock performance of must-know Cannabis stocks Curaleaf Holdings (LDVTF), Trulieve (TCNNF), WeedMD (WDDMF), Maricann (MRRCF), MedMen (MMNFF), Golden Leaf Holdings (GLDFF), and Vivo Cannabis (VVCIF) over the last week.
Curaleaf Holdings (LDVTF) is one of the leading cannabis companies in the United States. Curaleaf Holdings is set to release its Q3 2018 earnings today at 4:30 PM EST. In this article, we’ll look at Wall Street analyst expectations for Curaleaf’s Q3 earnings.
The Cannabis stocks we discuss in this series include WeedMD (WDDMF), Curaleaf Holdings (LDVTF), Trulieve (TCNNF), Maricann (MRRCF), MedMen (MMNFF), Golden Leaf Holdings (GLDFF), and Vivo Cannabis (VVCIF). Let’s take a look at the must-know developments and stock price performance for these companies last week.
The company reported revenues of $28.3 million during the third quarter of 2018 as compared to Wall Street analyst estimates of $26.6 million (or 35.1 million Canadian dollars) during the quarter. The below chart compares revenues for Trulieve since the third quarter of 2017. The Horizons Marijuana Life Sciences Index ETF (HMMJ) holds 11.8% of its total investments in Tilray (TLRY), 0.5% in WeedMD (WMD) (WDDMF), and 1.0% in Vivo Cannabis (VVCIF).